Dr. Hulgan has co-directed a CFAR Scientific Working Group and been a member of the Executive Committee. Dr. Hulgan’s research seeks to improve the health of HIV-infected persons by better understanding, predicting, preventing, and treating complications of HIV infection and antiretroviral therapy. An area of primary focus includes the field of translational mitochondrial genomics in HIV. Current phenotypes of interest are neurocognition and neuroinflammation. The ultimate vision for this work is to provide new knowledge and tools (genomic and/or biological markers) that inform a “precision-medicine” approach to improve treatment and management decisions for clinical care- and thus the length and quality of life- of an aging population of HIV infected persons. Dr. Hulgan maintains an active clinical and teaching program, having cared for HIV-infected patients for almost 20 years, and mentoring several Infectious Diseases fellows each year at the Nashville VA Hospital.